Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer: A Phase II Trial

NCT07130240 is registered in ClinicalTrials.gov with Obstetrics & Gynecology Hospital of Fudan University as lead sponsor.

NCT NCT07130240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07130240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer: A Phase II Trial
Lead sponsor
Obstetrics & Gynecology Hospital of Fudan University
Phase
Phase 2
Overall status
Recruiting
Start date
August 15, 2025
Completion date
August 31, 2030
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancers